[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hiv-prevention-program\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hiv-prevention-program":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,51],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":33,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":50},"100609717","phase-4-enhancing-prep-uptake-and-retention-among-latine-tgw-and-gbm-in-the-south-using-long-acting-injectable-prep-100609717",false,"NCT07218211","Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP","INCLUSION - Enhancing PrEP Uptake and Retention Among Latine Transgender Women and Gay, Bisexual, and Other Men Who Have Sex With Men in the South Using Long-Acting Injectable PrEP","INCLUSION","Inclusion Criteria:\n\n* Participants must be assigned male sex at birth.\n* Report sexual activity with a someone assigned male at birth OR identify as GBM or TGW; be HIV-negative.\n* Identify as Hispanic and\u002For Latine .\n* Be able to provide informed consent in English or Spanish .\n* Be 18 years or older .\n* Weigh at least 77 lbs (35 kg) by self-reported weight.\n* Interested in PrEP and willing to undergo the study procedures.\n\nExclusion Criteria:\n\n* Individuals living with HIV.\n* Individuals assigned female sex at birth will be excluded.\n* Individuals who are currently taking oral PrEP from another source and are not willing to switch to lenacapavir for PrEP for the duration of the study will also be excluded.\n* Individuals who report a history of severe renal or hepatic disease or with clinical stigmata of either disease on physical exam as assessed by a study clinician will be excluded.\n* Individuals taking a medication with a significant interaction with lenacapavir will be excluded from the study.",true,"MALE","18 Years",{"count":21,"type":22},100,"ESTIMATED","INTERVENTIONAL",[25],"PHASE4","The purpose of this project is to test a culturally-tailored, community-delivered long-acting injectable PrEP (lenacapavir) program for Latine gay and bisexual men (GBM) and transgender women (TGW). The objective is to evaluate whether this intervention demonstrates greater persistence on lenacapavir for Latine GBM and TGW compared with what has been observed historically at the Duke PrEP Clinic.",[28,29,30,31,32],"HIV Prevention","HIV Pre-exposure Prophylaxis","HIV Prevention Program","HIV Prevention and Care","HIV Pre-exposure Prophylaxis Use",[34,35,36,37],"Long-acting Injectable PrEP","Lenacapavir","PrEP","PrEP injections","RECRUITING","2026-01-29",{"date":41,"type":42},"2026-02-02","ACTUAL",{"date":44,"type":42},"2026-01-13",{"date":46,"type":22},"2028-01-05",{"name":48,"class":49},"Duke University","OTHER",1,{"id":52,"slug":53,"hasResults":11,"nctId":54,"briefTitle":55,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":17,"sex":58,"minAge":19,"maxAge":4,"enrollmentInfo":59,"targetDuration":4,"studyType":23,"phases":61,"briefSummary":63,"conditions":64,"keywords":65,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":50},"100577906","academic-detailing-to-optimize-prep-implementation-in-pediatric-primary-care-settings-adopt-prep-100577906","NCT06804382","Academic Detailing to Optimize PrEP Implementation in Pediatric Primary Care Settings: ADOPT-PrEP","ADOPT-PrEP","Inclusion Criteria:\n\n* Primary care provider at one of our 3 study sites (Boston Children's Hospital Adolescent\u002FYoung Adult Medicine, Martha Eliot Health Center, Children's Hospital Primary Care Center)\n\nExclusion Criteria:\n\n* None","ALL",{"count":60,"type":22},50,[62],"NA","In this study, 50 pediatricians will participate in academic detailing, an evidence-based, 1-on-1 outreach education technique intended to promote clinician behavior change through brief, highly interactive, and individualized dialogues with trained educators, or \"detailers\". The goals of this study are to learn about whether this is a practical and acceptable technique, and whether it changes how pediatricians prescribe pre-exposure prophylaxis (PrEP) to adolescents and young adults (AYA) and how patients take it.",[36,30],[36,66,67,68,69,70],"STI","AYA","adolescent","hiv prevention","academic detailing","NOT_YET_RECRUITING","2026-01-23",{"date":74,"type":42},"2026-01-26",{"date":76,"type":22},"2027-04-01",{"date":78,"type":22},"2030-03-30",{"name":80,"class":49},"Boston Children's Hospital"]